sábado, 7 de febrero de 2026
HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy The FDA also plans to ‘restrict the use’ of active ingredients used in compounded versions
https://www.statnews.com/pharmalot/2026/02/06/fda-take-action-against-hims-telehealth-wegovy-compounding/
By Ed SilvermanFeb. 6, 2026
Pharmalot Columnist, Senior Writer
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario